Gestational Trophoblastic Disease: Best Practice Nursing Guidelines
Conclusion Despite the many different models of care and resources available to GTD services this consensus working group have provided a set of guidelines to drive forward a pati ent focused holistic model of care for GTD patients. (Source: Gynecologic and Obstetric Investigation)
Source: Gynecologic and Obstetric Investigation - April 11, 2023 Category: OBGYN Source Type: research

Exploring the Safety Profile of Ornidazole as Drug Candidate for Endometriosis Treatment
- (Source: Gynecologic and Obstetric Investigation)
Source: Gynecologic and Obstetric Investigation - April 4, 2023 Category: OBGYN Source Type: research

Angiotensin Converting Enzyme ( < i > ACE < /i > ) Gene I/D Polymorphism Is Significantly Associated with Insulin Resistance and Polycystic Ovary Syndrome: A Meta-Analysis
Conclusions: The D allele of theACE I/D polymorphism promotes PCOS development. Moreover, theACE I/D polymorphism was also associated with insulin-resistant PCOS, especially among Asians. (Source: Gynecologic and Obstetric Investigation)
Source: Gynecologic and Obstetric Investigation - March 24, 2023 Category: OBGYN Source Type: research

Angiotensin converting enzyme (ACE) gene I/D polymorphism is significantly associated with insulin resistance and polycystic ovary syndrome: a meta-analysis
Conclusions: The D allele of the ACE I/D polymorphism promotes PCOS development. Moreover, the ACE I/D polymorphism was also associated with insulin-resistant PCOS, especially among Asians. (Source: Gynecologic and Obstetric Investigation)
Source: Gynecologic and Obstetric Investigation - March 24, 2023 Category: OBGYN Source Type: research

Surgical Efficacy among Laparoscopic Ultrasonic Dissectors in adenomyosis
Objectives: The present study aimed to investigate the efficacy of ultrasonic dissectors for adenomyomectomy using the double/multiple-flap method combined with temporary occlusion of the temporary bilateral uterine artery and the utero-ovarian vessels for the treatment of symptomatic adenomyosis. Design:This was a retrospective study Participants/Materials: In total 162 patients with symptomatic adenomyosis, and all of the them had originally been scheduled to group A (n = 82) and group B (n = 80) with each group representing with a different surgical applicance. All eligible women were informed of the potential complic...
Source: Gynecologic and Obstetric Investigation - March 20, 2023 Category: OBGYN Source Type: research

Total Flavonoids of < i > Polygala fallax Hemsl < /i > Induce Apoptosis of Human Ectopic Endometrial Stromal Cells through PI3K/AKT/Bcl-2 Signaling Pathway
Conclusion: PFHF reduces the expression of PI3K, AKT, Bcl-2, and Bcl-xl through the PI3K/AKT/Bcl-2 signaling pathway to inhibit HEcESCs proliferation, migration, and invasion and promote their apoptosis. (Source: Gynecologic and Obstetric Investigation)
Source: Gynecologic and Obstetric Investigation - March 17, 2023 Category: OBGYN Source Type: research

Total flavonoids of Polygala fallax Hemsl induce apoptosis of human ectopic endometrial stromal cells through PI3K/AKT/Bcl-2 signaling pathway
Abstract Objective: to explore the inhibitory effect of total flavonoids of Polygala fallax Hemsl (PFHF) on human ectopic endometrial stromal cells (HEcESCs) and its mechanism. Design: The potential targets and pathways of PFHF in the treatment of endometriosis were predicted by network pharmacology. The effect of PFHF on the proliferation, apoptosis and cell cycle, migration and invasion of HEcESCs (Fresh human ovarian endometriosis tissue was used for primary culture)was detected by CCK-8 method, flow cytometry and Transwell chamber experiment. Label-free quantitative proteomics based on mass spectrometry was used to a...
Source: Gynecologic and Obstetric Investigation - March 17, 2023 Category: OBGYN Source Type: research

Expression of HMGB1-TLR4 in placentas from preeclamptic pregnancies and its effect on proliferation and invasion of HTR-8/SVneo cells
This study aimed to investigate the expression of the high mobility box group 1 (HMGB1)-toll-like receptor 4 (TLR4) signalling pathway in preeclamptic placentas and determine whether HMGB1 regulates the biological behaviour of trophoblasts in vitro. Design: Placental biopsies were taken from 30 preeclamptic patients and 30 normotensive controls. In vitro experiments were carried out in HTR-8/SVneo human trophoblast cells. Participants/Materials, Setting, Methods: HMGB1, TLR4, and nuclear factor kappa B (NF- κB) mRNA and protein were quantified to compare their expression in human placentas from preeclamptic and normot...
Source: Gynecologic and Obstetric Investigation - March 7, 2023 Category: OBGYN Source Type: research

Low-Dose Aspirin Has Antiproliferative and Apoptosis Effects in HPV16 Tumor Cells and Delays Tumor Development and Growth in an Experimental Model
Conclusion: Aspirin showed antiproliferative effects in tumor cells and inhibited tumor progression and could be effective as a chemopreventive agent. Thus, aspirin deserves further exploration for the treatment of cervical cancer and other neoplasms. (Source: Gynecologic and Obstetric Investigation)
Source: Gynecologic and Obstetric Investigation - March 7, 2023 Category: OBGYN Source Type: research

Low-dose aspirin has antiproliferative and apoptosis effects in HPV-16 tumor cells and delays tumor-development and growth in an experimental model
Conclusion: Aspirin showed antiproliferative effects in tumor cells and inhibited tumor progression and could be effective as a chemopreventive agent. Thus, aspirin deserves further exploration for the treatment of cervical cancer and other neoplasms. (Source: Gynecologic and Obstetric Investigation)
Source: Gynecologic and Obstetric Investigation - March 7, 2023 Category: OBGYN Source Type: research

RETRACTED - RETRACTED - Retraction Statement
Gynecol Obstet Invest 2023;88:133 (Source: Gynecologic and Obstetric Investigation)
Source: Gynecologic and Obstetric Investigation - February 14, 2023 Category: OBGYN Source Type: research

RETRACTED - Retraction Statement
Gynecol Obstet Invest 2023;88:133 (Source: Gynecologic and Obstetric Investigation)
Source: Gynecologic and Obstetric Investigation - February 14, 2023 Category: OBGYN Source Type: research

Retraction Statement
Gynecol Obstet Invest (Source: Gynecologic and Obstetric Investigation)
Source: Gynecologic and Obstetric Investigation - February 14, 2023 Category: OBGYN Source Type: research

Expression of Concern
Gynecol Obstet Invest (Source: Gynecologic and Obstetric Investigation)
Source: Gynecologic and Obstetric Investigation - February 9, 2023 Category: OBGYN Source Type: research